Tags

Type your tag names separated by a space and hit enter

Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics.

Abstract

Although for most children the process of atherosclerosis is subclinical, dramatically accelerated atherosclerosis occurs in some pediatric disease states, with clinical coronary events occurring in childhood and very early adult life. As with most scientific statements about children and the future risk for cardiovascular disease, there are no randomized trials documenting the effects of risk reduction on hard clinical outcomes. A growing body of literature, however, identifies the importance of premature cardiovascular disease in the course of certain pediatric diagnoses and addresses the response to risk factor reduction. For this scientific statement, a panel of experts reviewed what is known about very premature cardiovascular disease in 8 high-risk pediatric diagnoses and, from the science base, developed practical recommendations for management of cardiovascular risk.

Links

  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA.

    , , , , , , , , , , , , , ,

    Source

    Circulation 114:24 2006 Dec 12 pg 2710-38

    MeSH

    Arthritis, Rheumatoid
    Atherosclerosis
    Cardiovascular Diseases
    Child
    Chronic Disease
    Diabetes Complications
    Diabetes Mellitus, Type 1
    Diabetes Mellitus, Type 2
    Evidence-Based Medicine
    Heart Defects, Congenital
    Heart Transplantation
    Humans
    Hyperlipoproteinemia Type II
    Kidney Diseases
    Lupus Erythematosus, Systemic
    Mucocutaneous Lymph Node Syndrome
    Neoplasms
    Risk Factors
    Risk Reduction Behavior

    Pub Type(s)

    Journal Article
    Review

    Language

    eng

    PubMed ID

    17130340

    Citation

    Kavey, Rae-Ellen W., et al. "Cardiovascular Risk Reduction in High-risk Pediatric Patients: a Scientific Statement From the American Heart Association Expert Panel On Population and Prevention Science; the Councils On Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group On Quality of Care and Outcomes Research: Endorsed By the American Academy of Pediatrics." Circulation, vol. 114, no. 24, 2006, pp. 2710-38.
    Kavey RE, Allada V, Daniels SR, et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2006;114(24):2710-38.
    Kavey, R. E., Allada, V., Daniels, S. R., Hayman, L. L., McCrindle, B. W., Newburger, J. W., ... Steinberger, J. (2006). Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation, 114(24), pp. 2710-38.
    Kavey RE, et al. Cardiovascular Risk Reduction in High-risk Pediatric Patients: a Scientific Statement From the American Heart Association Expert Panel On Population and Prevention Science; the Councils On Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group On Quality of Care and Outcomes Research: Endorsed By the American Academy of Pediatrics. Circulation. 2006 Dec 12;114(24):2710-38. PubMed PMID: 17130340.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. AU - Kavey,Rae-Ellen W, AU - Allada,Vivek, AU - Daniels,Stephen R, AU - Hayman,Laura L, AU - McCrindle,Brian W, AU - Newburger,Jane W, AU - Parekh,Rulan S, AU - Steinberger,Julia, AU - ,, AU - ,, AU - ,, AU - ,, AU - ,, AU - ,, AU - ,, AU - ,, Y1 - 2006/11/27/ PY - 2006/11/30/pubmed PY - 2007/1/4/medline PY - 2006/11/30/entrez SP - 2710 EP - 38 JF - Circulation JO - Circulation VL - 114 IS - 24 N2 - Although for most children the process of atherosclerosis is subclinical, dramatically accelerated atherosclerosis occurs in some pediatric disease states, with clinical coronary events occurring in childhood and very early adult life. As with most scientific statements about children and the future risk for cardiovascular disease, there are no randomized trials documenting the effects of risk reduction on hard clinical outcomes. A growing body of literature, however, identifies the importance of premature cardiovascular disease in the course of certain pediatric diagnoses and addresses the response to risk factor reduction. For this scientific statement, a panel of experts reviewed what is known about very premature cardiovascular disease in 8 high-risk pediatric diagnoses and, from the science base, developed practical recommendations for management of cardiovascular risk. SN - 1524-4539 UR - https://www.unboundmedicine.com/medline/citation/17130340/full_citation L2 - http://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.106.179568?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -